Hydrogen sulfide (H₂S) is a gaseous signaling molecule and the third "gas transmitter" alongside nitric oxide and carbon monoxide. It is produced both by sulfate-reducing bacteria in the gut (particularly Desulfovibrio) and by mammalian cells via three enzymatic pathways: CBS (cystathionine β-synthase), CSE (cystathionine γ-lyase), and 3MST (3-mercaptopyruvate sulfurtransferase). At physiological concentrations (<0.1 μM in serum), H₂S functions as a signaling molecule regulating vascular tone, neurotransmission, and mitochondrial respiration; at pathological concentrations (>1 μM), it becomes cytotoxic, inhibiting cytochrome c oxidase and damaging epithelial cells.
Imagine your cellular powerplant (mitochondria) as a factory with a delicate ventilation system. H₂S is like a gas that can either adjust the thermostat in tiny doses or become toxic fumes in high concentrations. When your gut bacteria—specifically the "sulfur refineries" (sulfate-reducing bacteria like Desulfovibrio)—consume dietary sulfates and sulfur-containing proteins, they pump out H₂S into your intestinal lumen. At low levels, this gas acts like a gentle breeze through the factory, fine-tuning machinery and keeping workers alert. But when the sulfur refineries go into overdrive (as in H2S SIBO), the factory floor floods with rotten-egg-smelling fumes that jam the main power generator (complex IV of the electron transport chain). The workers can't breathe, energy production crashes, and the factory walls (intestinal epithelium) start to corrode. Your body's own cells also make small amounts of H₂S in a controlled way—like having a built-in gas regulator—but when bacterial production overwhelms this system, you get the telltale sign: flatulence that smells like sulfur (rotten eggs), not the sweet fermentation smell from regular bacteria.
H₂S is produced via two distinct pathways: bacterial and mammalian endogenous synthesis.
Sulfate-reducing bacteria (SRB) in the gut—primarily Desulfovibrio, Fusobacterium, and certain Clostridium species—use dissimilatory sulfate reduction as an energy-yielding process:
- Dietary sulfate + sulfur-containing amino acids (cysteine, methionine) + sulfated mucins → H₂S
- The enzyme dissimilatory sulfite reductase (DsrAB) catalyzes the final reduction: SO₃²⁻ → H₂S
- Optimal bacterial H₂S production occurs at neutral to slightly alkaline pH (7.0-7.5); low pH (<6.5) inhibits SRB activity
- Colonic SRB produce millimolar concentrations locally, creating a gradient toward epithelial cells
Three enzymatic pathways generate H₂S from L-cysteine:
-
CBS pathway (cystathionine β-synthase):
- Cysteine + homocysteine → cystathionine + H₂S
- Requires vitamin B6 (pyridoxal-5'-phosphate) as cofactor
- Highly expressed in brain and liver
- Regulated by S-adenosylmethionine (SAM) as allosteric activator
-
CSE pathway (cystathionine γ-lyase):
- Cystathionine → cysteine + α-ketobutyrate + H₂S
- Also converts cysteine directly to pyruvate + H₂S
- Predominant in cardiovascular system
- Calcium-calmodulin dependent
-
3MST pathway (3-mercaptopyruvate sulfurtransferase):
- Cysteine + α-ketoglutarate (via CAT enzyme) → 3-mercaptopyruvate + glutamate
- 3-mercaptopyruvate + thioredoxin → pyruvate + H₂S
- Localized to mitochondria and cytosol
- Works in tandem with cysteine aminotransferase (CAT)
Physiological signaling (nanomolar to low micromolar):
- H₂S → persulfidation of target proteins (adds -SSH groups to cysteine residues)
- Activates ATP-sensitive K⁺ channels (KATP) → vascular smooth muscle relaxation
- Stimulates VEGF expression → angiogenesis
- Upregulates Nrf2 → antioxidant defense
- Modulates NMDA receptor activity → neurotransmission
Pathological toxicity (>1 μM sustained):
graph TD
A[Dietary Sulfate/Sulfur AA] --> B[Sulfate-Reducing Bacteria]
B --> C[Dissimilatory Sulfite Reductase]
C --> D["H₂S Production"]
E[L-Cysteine] --> F[CBS Pathway]
E --> G[CSE Pathway]
E --> H[3MST Pathway]
F --> I["Endogenous H₂S"]
G --> I
H --> I
D --> J{Concentration}
I --> J
J -->|"Low < 0.1 μM"| K[Signaling Functions]
J -->|"High > 1 μM"| L[Cytotoxicity]
K --> M[KATP Channel Activation]
K --> N[Protein Persulfidation]
K --> O[Nrf2 Upregulation]
L --> P[Cytochrome c Oxidase Inhibition]
P --> Q[ATP Depletion]
P --> R[ROS Generation]
R --> S[Epithelial Damage]
S --> T[Intestinal Permeability]
T --> U[Inflammation/Ulceration]
H₂S dysregulation is a critical factor in multiple gut dysbiosis conditions and systemic pathologies:
H2S SIBO ("Smelly SIBO"):
- Overgrowth of SRB in small intestine produces excessive H₂S
- Cardinal symptom: rotten-egg odor flatulence (vs. sweet-smelling fermentation)
- Other symptoms: diarrhea (osmotic and secretory), bloating, abdominal pain
- Breath test: elevated H₂S (>3 ppm is considered positive, though testing is controversial)
- Treatment: reduce dietary sulfate/sulfur (limit cruciferous vegetables, eggs, garlic), bismuth subsalicylate (binds H₂S), low-sulfur diet, targeted antimicrobials (rifaximin may worsen; bismuth + neomycin preferred)
IBD and ulcerative colitis:
- Studies show 3-10× higher fecal H₂S in UC vs. controls (up to 3-5 mM in active disease)
- H₂S directly damages colonocytes → ulceration, particularly in distal colon
- Desulfovibrio abundance correlates with disease severity
- Mucosal biopsies show upregulated CBS and CSE in inflamed tissue (compensatory attempt to scavenge H₂S?)
- Interventions: reduce dietary sulfate, probiotics that compete with SRB (Lactobacillus, Bifidobacterium), butyrate supplementation (colonocyte fuel reduces reliance on damaged mitochondria)
Mitochondrial dysfunction and fatigue:
pH and fermentation patterns:
- pH regulation in gut lumen is critical: low pH (<6.5) suppresses SRB, favoring lactic acid bacteria
- High colonic pH (>7.0) from reduced SCFA production allows SRB overgrowth
- Diagnostic clue: sweet-smelling flatulence suggests carbohydrate fermentation (H₂ and CO₂); foul-smelling suggests H₂S
- Therapeutic pH manipulation: butyrate supplementation, resistant starch (feeds butyrate-producers), betaine HCl (lowers stomach pH, cascades down)
Connection to selfish immune system:
- H₂S-producing bacteria can exploit host nutrient availability during inflammation
- Inflammation → increased mucosal sulfate secretion (sulfomucins) → feeds SRB → more H₂S → more inflammation (vicious cycle)
- Represents bacterial "hijacking" of host inflammatory response for competitive advantage
Mismatch dimension:
- Modern high-protein, high-sulfate diets (processed meats, preservatives like sulfites) create evolutionary mismatch
- Hunter-gatherer diets lower in sulfur-containing amino acids, higher in fermentable fiber → balanced microbiome
- Western diet shifts toward SRB dominance, away from butyrate-producers
- H₂S is the third gas transmitter alongside nitric oxide (NO) and carbon monoxide (CO)
- Physiological serum concentration: <0.1 μM; pathological: >1 μM sustained
- Primary bacterial producers: Desulfovibrio (most studied), Fusobacterium, sulfate-reducing Clostridium species
- Mammalian production via three enzymes: CBS (brain/liver), CSE (cardiovascular), 3MST (mitochondrial)
- CBS requires vitamin B6 (P5P) as cofactor; deficiency impairs endogenous H₂S regulation
- Rotten-egg odor flatulence is pathognomonic for H₂S overproduction (vs. sweet-smelling = carbohydrate fermentation)
- Ulcerative colitis patients show fecal H₂S concentrations 3-10× higher than controls (up to 3-5 mM)
- H₂S inhibits cytochrome c oxidase (complex IV) at IC₅₀ ~0.2 μM, blocking electron transport chain
- Low intestinal pH (<6.5) inhibits SRB activity; neutral-alkaline pH (7.0-7.5) favors H₂S production
- Bismuth subsalicylate binds H₂S, forming insoluble bismuth sulfide (black stool is therapeutic marker)
- Breath testing for H₂S is controversial; most labs measure H₂ and CH₄, infer H₂S from flat-line pattern with symptoms
- Chronic H₂S exposure → 60-80% reduction in cellular ATP production
- H₂S persulfidates (adds -SSH to) >25% of cellular proteins at physiological concentrations, modulating their function
- Dietary sulfate intake >800 mg/day (typical Western diet) significantly increases fecal H₂S vs. <400 mg/day
- sulfate-reducing bacteria — primary gut producers of H₂S, utilizing dissimilatory sulfate reduction for energy
- Desulfovibrio — dominant SRB genus in human gut; correlates with IBD severity and H₂S levels
- Fusobacterium — anaerobic bacterium capable of H₂S production; associated with colorectal cancer
- H2S SIBO — small intestinal overgrowth syndrome characterized by excess H₂S; causes rotten-egg flatulence
- SIBO — H₂S-producing variant is distinct from hydrogen/methane SIBO; requires different treatment approach
- ulcerative colitis — chronic inflammatory condition with 3-10× elevated fecal H₂S; damages distal colon epithelium
- IBD — both UC and Crohn's show dysbiotic shifts toward SRB and elevated H₂S production
- CBS — cystathionine β-synthase; transsulfuration pathway enzyme producing endogenous H₂S in brain/liver
- CSE — cystathionine γ-lyase; cardiovascular H₂S-producing enzyme; regulates vascular tone
- 3MST — 3-mercaptopyruvate sulfurtransferase; mitochondrial H₂S pathway working with CAT enzyme
- cytochrome c oxidase — complex IV of electron transport chain; competitively inhibited by H₂S at Fe³⁺ site
- mitochondrial dysfunction — caused by chronic H₂S inhibition of respiratory enzymes; systemic energy depletion
- ATP production — reduced 60-80% when H₂S inhibits complex IV; underlies fatigue in H₂S-dominant dysbiosis
- intestinal permeability — increased by H₂S-induced oxidative damage to tight junction proteins (ZO-1, occludin)
- inflammation — perpetuated by H₂S epithelial injury and ROS generation; feeds SRB via sulfomucin secretion
- flatulence — rotten-egg odor is diagnostic for H₂S overproduction; sweet odor suggests carbohydrate fermentation
- diarrhea — osmotic and secretory mechanisms in H₂S SIBO; epithelial damage impairs absorption
- pH regulation — low intestinal pH (<6.5) suppresses SRB; alkaline pH (>7.0) promotes H₂S production
- butyrate — SCFA that lowers colonic pH, fuels colonocytes, competitively inhibits SRB overgrowth
- nitric oxide — fellow gas transmitter with complementary vasodilatory signaling; can interact with H₂S (cross-talk)
- gut dysbiosis — H₂S overproduction indicates SRB dominance; loss of butyrate-producing diversity
- SCFA — short-chain fatty acids from fiber fermentation; reduced production raises pH, favoring SRB
- microbiome — H₂S producers represent ~1-2% of healthy gut bacteria; can expand to >10% in dysbiosis
- cysteine — sulfur-containing amino acid; substrate for both bacterial and mammalian H₂S production
- methionine — sulfur amino acid metabolized to cysteine via transsulfuration; excess increases H₂S substrate
- chronic fatigue syndrome — often shows dysbiotic patterns with H₂S overproduction; mitochondrial dysfunction link
- fibromyalgia — systemic pain condition associated with gut dysbiosis, potential H₂S mitochondrial toxicity
- reactive oxygen species — generated when H₂S stalls electron transport chain; damages epithelial DNA/lipids
- electron transport chain — H₂S blocks complex IV, backing up electrons to generate superoxide at complexes I/III
- oxidative stress — H₂S paradox: antioxidant at low doses (Nrf2 activation), pro-oxidant at high doses (ROS generation)
- Nrf2 — transcription factor upregulated by low-dose H₂S; induces antioxidant response elements
- KATP channels — ATP-sensitive potassium channels activated by physiological H₂S; cause vasodilation
- VEGF — vascular endothelial growth factor; upregulated by low-dose H₂S signaling; promotes angiogenesis
- Lactobacillus — beneficial bacteria that compete with SRB for nutrients; lower gut pH via lactic acid
- Bifidobacterium — saccharolytic bacteria; produce acetate/lactate, create acidic environment hostile to SRB
- tight junctions — epithelial barrier structures (ZO-1, occludin) damaged by chronic H₂S and ROS exposure
- mucins — sulfated glycoproteins in mucus layer; degraded by SRB as sulfate source for H₂S production
- Module 6 — Organs I (gut microbiome, H₂S SIBO pathophysiology)
- Module 10 — Movement & Nutrition (sulfur metabolism, mitochondrial function, dietary sulfur/sulfate)